Texas Oncology - Medical City Dallas — Dallas, Texas

Texas Oncology - Medical City Dallas is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Texas Oncology - Medical City Dallas has participated in 18 clinical trials with 4 currently active.

Therapeutic areas: Relapsed/Refractory Diffuse Large B-cell Lymphoma, Metastatic Breast Cancer, Breast Cancer.

Sponsors: Karyopharm Therapeutics Inc, Eli Lilly and Company, Julie Nangia.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - Medical City Dallas?

Texas Oncology - Medical City Dallas has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - Medical City Dallas conducted?

Texas Oncology - Medical City Dallas has 18 clinical trials on record, with 4 currently active. Their work covers Relapsed/Refractory Diffuse Large B-cell Lymphoma, Metastatic Breast Cancer, Breast Cancer.

Is Texas Oncology - Medical City Dallas accredited by Crixeo Health?

Texas Oncology - Medical City Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology - Medical City Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.